Celdara Medical today announced its ranking by Business NH Magazine as the fastest growing company in New Hampshire. This marks the sixth consecutive year that Celdara has ranked in the top 10, and the third consecutive year at the top of the list. Rankings are across all sectors, and are based on three-year average annual growth rate.
Celdara Medical, LLC today announced that the National Institute of Allergy and Infectious Diseases of the National Institutes of Health has awarded a two-year, Small Business Innovation Research contract to fund the company’s discovery pipeline for treatment of Crohn’s Disease and other autoimmune diseases. This project will be developed in partnership with Dr. Sara Lustigman at the New York Blood Center.
Celdara Medical, LLC and The Geisel School of Medicine at Dartmouth College today announced the selection of three outstanding researchers as the recipients of the 2018 Dartmouth SYNERGY/Celdara Medical High-Potential Entrepreneurs’ Fellowships (DS-CHEF).
Celdara Medical, LLC announced today that it has received a three-year, $3.5 million award from the National Institutes of Health (NIH) to support an Institutional Development Award (IDeA) Center of Biomedical Research Excellence. Celdara Medical has been selected to create and operate a Regional Technology Transfer Accelerator Hub in the Northeast (the DRIVEN Accelerator Hub: DE, RI, VT, ME, and NH).
BURLINGTON, VT and LEBANON, NH – New translational research, published in Nature Medicine, demonstrates a novel biological therapeutic candidate for regressing pulmonary fibrosis in a difficult-to-treat preclinical model of the disease, providing much-needed hope for the roughly 150,000 Americans suffering from this devastating condition. A chronic, progressive disease marked by […]
Celdara Medical, LLC, a privately-held company advancing early stage innovation into the clinic, is pleased to announce the appointment of Shruti Abbato as Vice President of Business Development. Abbato brings a wealth of experience in biopharma business development and will lead partnering activities across the company from Celdara’s Washington DC […]
Celdara Medical, LLC has been recognized as the fastest growing company in the State of New Hampshire by Business NH Magazine. This award is based on 3-year average revenue growth, where Celdara delivered a 193% AAGR, leading all companies in all categories. This is the 5th consecutive year that Celdara […]
Celdara Medical and The Geisel School of Medicine at Dartmouth today announced the selection of two outstanding researchers as the recipients of the 2017 Dartmouth SYNERGY/Celdara Medical High-Potential Entrepreneurs’ Fellowships (DS-CHEF). The program provides a part-time, year-long experiential learning opportunity at Celdara Medical to graduate student and post-doctoral researchers affiliated […]
Celdara Medical, LLC today announced that it has successfully concluded negotiations with Celyad SA (Euronext Brussels and Paris, and NASDAQ:CYAD) related to their ongoing partnership for discovery and development of CAR T cell therapies. Celyad, a Belgium-based cell therapy company, obtained access to its CAR T cell drug product candidates […]
Celdara Medical, LLC today announced that the National Cancer Institute of the National Institutes of Health has awarded a two-year, $2 million Phase II Small Business Innovation Research grant to fund the company’s development of a B cell focused immunotherapy to treat melanoma and other cancers. The biologic, CM-JG01, targets […]